T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis

被引:112
作者
Chauhan, B
Knutsen, AP
Hutcheson, PS
Slavin, RG
Bellone, CJ
机构
[1] ST LOUIS UNIV,HLTH SCI CTR,DEPT MOLEC MICROBIOL & IMMUNOL,SCH MED,ST LOUIS,MO 63104
[2] ST LOUIS UNIV,SCH MED,DEPT INTERNAL MED,ST LOUIS,MO 63104
[3] ST LOUIS UNIV,SCH MED,DEPT PEDIAT,ST LOUIS,MO 63104
关键词
allergic bronchopulmonary aspergillosis; T cell clones; HLA-restriction; epitope mapping; cytokines;
D O I
10.1172/JCI118675
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity lung disease characterized by Aspergillus fumigatus (Af) colonization, IgE and IgG anti-Af antibodies, pulmonary infiltrates, bronchiectasis, and pulmonary fibrosis, Little is known regarding T cell responses and their role in the pathogenesis of ABPA, To examine T cell reactivity to Af antigens, T cell clones (TCC) specific to the Asp fl antigen, an 18-kD protein of Af, were established from the peripheral blood of three ABPA patients. The majority of TCC isolated from ABPA patients, and specific for the Asp f 1 allergen of Af, are IL-4 producing CD4+ cells of the Th2 phenotype, Further analysis in this study revealed that the majority of TCC reacted to mainly two epitopes of Asp f 1, while the remaining TCC reacted to three additional ''minor'' epitopes. Blocking studies using monoclonal antibodies specific for class ZI HLA-D region gene products showed that most TCC, 19/21, were restricted by HLA-DR molecules, and the remaining two clones by HLA-DP molecules. The use of a panel of HLA-matched and mismatched EBV-transformed B cells as antigen presenting cells revealed that the HLA-DR restriction was mediated exclusively by either the HLA-DR2 or HLA-DRS alleles, Genotyping of DRB1 gene products showed that class II presentation for most clones was not restricted to a single allele, representing DRB1 gene products of either HLA-DR2 or DR5. These studies offer insight into the cellular and molecular determinants which contribute to the immunopathophysiology of ABPA, (J. Clin. Invest. 1995. 97:2324-2331.)
引用
收藏
页码:2324 / 2331
页数:8
相关论文
共 36 条
[1]  
ARRUDA LK, 1992, J IMMUNOL, V149, P3354
[2]   ASPERGILLUS-FUMIGATUS - IDENTIFICATION OF 16, 18, AND 45 KD ANTIGENS RECOGNIZED BY HUMAN-IGG AND IGE ANTIBODIES AND MURINE MONOCLONAL-ANTIBODIES [J].
ARRUDA, LK ;
PLATTSMILLS, TAE ;
LONGBOTTOM, JL ;
ELDAHR, JM ;
CHAPMAN, MD .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (06) :1166-1176
[3]   RA5 IMMUNE-RESPONSES, HLA ANTIGENS AND COMPLOTYPES [J].
BLUMENTHAL, M ;
AWDEH, Z ;
ALPER, C ;
YUNIS, E .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1985, 75 (01) :155-155
[4]   TREATMENT OF STEROID-DEPENDENT ASTHMA WITH RECOMBINANT INTERFERON-GAMMA [J].
BOGUNIEWICZ, M ;
SCHNEIDER, LC ;
MILGROM, H ;
NEWELL, D ;
KELLY, N ;
TAM, P ;
IZU, AE ;
JAFFE, HS ;
BUCALO, LR ;
LEUNG, DYM .
CLINICAL AND EXPERIMENTAL ALLERGY, 1993, 23 (09) :785-790
[5]   BEE VENOM PHOSPHOLIPASE-A2-SPECIFIC T-CELL CLONES FROM HUMAN ALLERGIC AND NONALLERGIC INDIVIDUALS - CYTOKINE PATTERNS CHANGE IN RESPONSE TO THE ANTIGEN CONCENTRATION [J].
CARBALLIDO, JM ;
CARBALLIDOPERRIG, N ;
TERRES, G ;
HEUSSER, CH ;
BLASER, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (06) :1357-1363
[6]  
DELPRETE G, 1988, J IMMUNOL, V140, P4193
[7]  
DELPRETE G, 1994, LAB INVEST, V70, P299
[8]   PURIFIED PROTEIN DERIVATIVE OF MYCOBACTERIUM-TUBERCULOSIS AND EXCRETORY-SECRETORY ANTIGEN(S) OF TOXOCARA-CANIS EXPAND INVITRO HUMAN T-CELLS WITH STABLE AND OPPOSITE (TYPE-1 T-HELPER OR TYPE-2 T-HELPER) PROFILE OF CYTOKINE PRODUCTION [J].
DELPRETE, GF ;
DECARLI, M ;
MASTROMAURO, C ;
BIAGIOTTI, R ;
MACCHIA, D ;
FALAGIANI, P ;
RICCI, M ;
ROMAGNANI, S .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) :346-350
[9]  
GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245
[10]   RA5G, A HOMOLOG OF RA5 IN GIANT RAGWEED POLLEN - ISOLATION, HLA-DR-ASSOCIATED ACTIVITY AND AMINO-ACID SEQUENCE [J].
GOODFRIEND, L ;
CHOUDHURY, AM ;
KLAPPER, DG ;
COULTER, KM ;
DORVAL, G ;
DELCARPIO, J ;
OSTERLAND, CK .
MOLECULAR IMMUNOLOGY, 1985, 22 (08) :899-906